Explained – Why Jefferies is bearish on Dr. Reddy’s and Cipla but bullish on Mankind Pharma

Jefferies has mixed views on pharma stocks. It has an “underperform” rating on Dr Reddy’s and Cipla, and a “buy” recommendation on Mankind Pharma.

Jefferies has mixed views on pharma stocks. It has an “underperform” rating on Dr Reddy’s and Cipla, and a “buy” recommendation on Mankind Pharma.

Hartmut Issel, Head APAC Equities, Global Wealth Management & CIO at UBS discusses why the West Asia tensions are unlikely to derail markets, how the AI investment theme is shifting beyond semiconductors, and why improving earnings and GDP growth could…

Trading activity also picked up in today’s session. Around 3.10 crore shares of Kalyan Jewellers changed hands on Thursday, in the first 45 minutes of trading.

Crude steel production from the company’s Indian operations rose 3% year-on-year to 6.35 million tonnes from 6.14 million tonnes and was up 0.3% from 6.32 million tonnes in the preceding quarter.

Gold prices dip as US-Iran tensions boost dollar, oil. Silver steady. Fed minutes, jobless claims awaited.

Graphite India to close its Graphite Specialties and Coating Divisions in Germany due to Russia-Ukraine war impact and weak demand. These divisions had a negative net worth.

SBI will sell 12.83 crore shares, or 6.3% of the company, while Amundi India Holding will divest 7.53 crore shares, accounting for the remaining 3.7%.

China’s consumer prices rose slower than expected in June, 1% year-on-year. Producer inflation accelerated to 4.1%, matching forecasts. Factory prices declined 0.3% month-on-month.

Reliance Industries is setting up a 10 GWh battery gigafactory at Jamnagar and is one of the beneficiaries under the government’s Advanced Chemistry Cell (ACC) Production Linked Incentive (PLI) scheme.

Sensex Today | Stock Market LIVE Updates: What could dampen sentiments is the fact that these developments come just as the market had begun to look past them and look forward to the results season that begins today with TCS…